+1 800 783 4636

Lonza Completes Acquisition of InterHealth Nutraceuticals

Sep 13, 2016 by Jawon Smith Comments: 0

Basel, Switzerland, 13 September 2016 – Lonza announced today that it has closed the acquisition of InterHealth Nutraceuticals, Inc. (“InterHealth”), a leader in research, development, manufacture and marketing of proprietary, value-added nutritional ingredients for use in dietary supplements, based in Benicia, CA (USA) from Kainos Capital. The InterHealth business will become part of Lonza’s Consumer Care Business Unit, but will retain its facilities and employees. The combination of the two businesses allows Lonza to offer InterHealth’s more than 15 branded ingredients, including its cornerstone ingredient, UC-II, which is revolutionizing the joint-health segment. “We are looking forward to welcoming the highly capable team to our Lonza family. They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets.” said Richard Ridinger, Lonza’s Chief Executive Officer. “Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.” Lonza acquired InterHealth for a total transaction price of up to USD 300 million split into an upfront payment and an earn-out payment. The transaction is expected to be immediately accretive to Lonza’s earnings.   About Lonza Lonza is […] Read More

Meratrim Venkateshwarlu

Aug 30, 2016 by Jawon Smith Comments: 0

Meratrim® Lipids Health Dis. 2016; 15(1): 136. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects. Venkateshwarlu Kudiganti,1 Raveendra Ramamurthy Kodur,1 Sushma Raveendra Kodur,1 Manjunath Halemane,2 andDheeraj Kumar Deep2 Abstract Background Meratrim is a blend of two plant extracts obtained from Sphaeranthus indicus flower heads and Garcinia mangostana fruit rinds. Previous studies have demonstrated that Meratrim is effective for weight management in obese individuals. The objective of this study was to assess the efficacy and tolerability of Meratrim in managing body weight in healthy overweight subjects. Methods Sixty participants with a mean BMI of 28.3 kg/m2 were randomized into two groups receiving either 400 mg of Meratrim twice daily or two identical placebo capsules for a period of 16 weeks. Subjects were asked to consume about 2,000 kcal/day throughout the study period and walk 5 days a week for 30 min daily. The primary endpoint was defined as the change in body weight from baseline to end of week 16 for the Meratrim group versus placebo. Fifty seven subjects completed the trial. Results At study conclusion, statistically significant reductions in body weight (5.09 vs. 1.1 kg; p < 0.0001), BMI (1.91 vs. 0.43 kg/m2; p < 0.0001), waist (9.97 vs. 3.71 cm; p < 0.001) and […] Read More

Significant Growth in Products Containing UC-II®

Jan 13, 2016 by Jawon Smith Comments: 0

UC-II® was recently mentioned in Chain Drug Review as a “promising innovation” within the joint health segment. The magazine points out that joint relief sales have been sinking as of late, and manufacturers have been searching for solutions in order to stimulate this $500 million segment. Industry analyst Kurt Jetta suggests that UC-II® is the solution. He highlights in his article the 60% growth of products that include this proprietary form of undenatured type II collagen. Reckitt Benckiser and NBTY, major players in the supplement industry, both sell products that include UC-II® and are filling up shelves in retail stores all over. “The fact that the growth has come from both distribution gains and velocity gains suggests that these products continue to find an audience and are poised for continued dynamic growth,” says Jetta. InterHealth CEO and President Paul Dijkstra is also quoted in the article: “We are trying to reactivate interest in joint relief by offering something other than traditional glucosamine derivatives…UC-II is a research-based ingredient that provides the efficacy consumers need with a smaller, easier-to-swallow pill size.” For more information about InterHealth or UC-II® contact us at info@interhealthusa.com or call us at 1-800-783-4636. Read More